Introduction
Recursion, a TechBio leader, leverages AI to accelerate drug discovery, focusing on Precision Oncology and Rare Diseases. This case study showcases how our formidable life science executive search firm helped Recursion build a visionary leadership team to fuel innovation, secure funding, and amplify patient impact.
%202%20(1).webp)
The Challenge
Building a TechBio Leadership Powerhouse Demanded a Comprehensive Approach.
· Cross-Disciplinary Expertise: Finding leaders who could integrate biology, AI, and data science was critical, as traditional candidates often lacked the diverse skillset and expansive imagination required to navigate such a complex landscape.
· Strategic Growth: With Recursion's rapid expansion, executives who had closed strategic partnerships, funding rounds, and IPOs would be essential to drive and sustain its growth.
The Solution
At Occam Global, our approach is guided by our philosophy of enlightened aggression - a blend of rigorous objectivity and ethical judgment. These cultural values enabled us to deliver transformative results through two key strategies:
· Targeted Executive Search: Leveraging our extensive network within the life sciences sector, we customized our search criteria to identify exceptional candidates with diverse, multifaceted expertise that met Recursion’s unique needs.
· Leadership Talent Cultivation: We developed candidates who complemented and balanced the existing leadership team, fostering an environment where empirical data, statistical precision, and synergistic thinking converge to address complex challenges.
· Key Placements Include:
o Chief Operating Officer Tina Marriott
o Chief Medical Officer David Mauro, M.D., Ph.D
o Chief Communications Officer Ryan Kelly
o Vice President Regulatory Affairs Jyoti Chauhan
o Board Member Terry-Ann Burrell
The Impact
Occam Global's strategic leadership placements have helped steer Recursion through its transformational growth:
· Operational Excellence: Enhanced efficiency, resource allocation & project prioritization, vital for integrating advanced tech and scientific disciplines.
· IPO Success: Supported Recursion's successful public launch in April of 2021.
· Strategic Readiness: Fostered key partnerships, including Exscientia, acquiring a chemistry oriented leader within a pipeline in the AI drug discovery space.
This case study demonstrates how strategic life science executive search and recruitment can transform TechBio companies in their pursuit of technological innovation and competitive differentiation. Furthermore, it highlights Occam Global's critical role in propelling Recursion's evolution from a startup to a disruptive force int he biopharma industry.
Contact us today to build your life science executive team.
Frequently Asked Questions
Occam Global provides global executive recruiting, board recruiting, and leadership advisory services.
With associates in New York, San Francisco, London, and Los Angeles, Occam serves clients across Europe the US, and Asia
We are specialists in recruiting executives and board members for the life sciences but serve a variety of other tech clients as well as venture capital.